Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.
- Resource Type
- journal article
- Source
- Clinical Lung Cancer; Nov2018, Vol. 19 Issue 6, pe823-e830, 8p
- Subject
- Language
- ISSN
- 15257304